Garenoxacin Mesylate hydrate (BMS284756 (Mesylate hydrate)) |
Catalog No.GC33950 |
가레녹사신(BMS284756) 메실레이트 수화물은 경구 활성 퀴놀론 항생제이며 다양한 그람 양성 및 그람 음성 박테리아, 혐기성 미생물 및 까다로운 유기체에 대해 광범위한 활성 스펙트럼을 가지고 있습니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 223652-90-2
Sample solution is provided at 25 µL, 10mM.
Garenoxacin mesylate hydrate is a novel oral des-fluoro(6) quinolone with potent antimicrobial activity, against common respiratory pathogens, including resistant strains.
[1]. Waites KB, et al. In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob Agents Chemother. 2003 Jan;47(1):161-5. [2]. Ince D, et al. Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone. Antimicrob Agents Chemother. 2002 Nov;46(11):3370-80. [3]. Zhao X, et al. Mutant prevention concentration of garenoxacin (BMS-284756) for ciprofloxacin-susceptible or -resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2003 Mar;47(3):1023-7.
Average Rating: 5
(Based on Reviews and 8 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *